Our advanced technology powers genetic research studies at Harvard’s McLean Hospital and other leading institutions, demonstrating our commitment to advancing precision wellness while making genetic insights accessible and actionable for every practice.
Our patented provider portal enhances the patient evaluation process through
Launch your branded DNA testing service with our comprehensive solution:
Physicians can now query a patient’s DNA file using generative AI, enabling unprecedented insights and personalized care.
Multiple clinical trials with Harvard’s McLean Hospital.
Research partnerships with Wayne State University.
Published studies on anxiety, PTSD, brain health, and more.
Join the rapidly expanding precision medicine market:
Global precision medicine market projected to
reach USD 249.24 billion by 2030
Strong 16.3% Compound Annual Growth Rate (CAGR) from 2024 to 2030
Rising demand for personalized wellness solutions driven by advances in genetic testing and AI
Schedule a consultation to learn how our AI-powered genetic insights can enhance your practice and create new revenue streams.
©2024 Endocanna Health, Inc. All rights reserved. The Endocanna Health Logo, EndoDNA, Cannabis is Personal and myDNA.live are trademarks of Endocanna Health, Inc.